GSK Maintains Transparency in their Payments

user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 10644 ORDER BY v.weight, t.weight, t.name in /home/germantr/public_html/topnewsae/modules/taxonomy/taxonomy.module on line 632.

Submitted by Kamilah Qasimi on Wed, 02/22/2012 - 12:36

Following the company policy, GlaxoSmithKline (GSK) Australia has cleared all its payments to other health care professionals. As told by Deborah Waterhouse, the General Manager of pharmaceuticals GSK, this disclosure of payments has been done keeping in mind the policy of the company.

As announced by the company, they have paid Australian health professionals and organisations more than $2.2 million in terms of fund from drug manufacturer.

During a collapse of the payments, it has been revealed that each and every individual pharmacist, doctor and other health professionals have been given $287,384 in terms of attending domestic and international conferences and symposia.

For conducting speaker presentations and for working over the clinical development of advisory boards, GSK has paid $372,695 to health professionals. Besides, $1.5 million has been paid to health related organizations in lieu of sponsorship, donations or grants.

Deborah Waterhouse said “We believe it is important to provide the community information on the benefits that come from relationships with healthcare professionals – improved patient care, new medical technologies, advances in research and improved dissemination of medical knowledge”.

She also stated the company to be transparent enough for releasing their data every year. By doing this, the company aims to have far better consumer confidence and this is the reason why they always support the inclusion of greater transparency in the Medicines Australia Code of Conduct.

According to the reports of GSK, since 2010, they have maintained steady payments to health professionals and organizations. However, there have been noticed a decrease in both grants and consultancy fee payments to individuals which has further resulted in a considerable increase in sponsorships to health related organisations.

From their total payment of $1.5 million to health organisations, GSK disclosed a payment of $505,553 to patient and community groups. This amount was given to them either in the form of financial support or donation.

»